biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Bioasis Connections

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Jun 24, 2022 9:24pm

164 Views

Post# 34781828

RE:RE:Bioasis Connections

I wish we could be all as smart as you !

Of course,the oblivious question would be ............. if you are So smart why are you so poor?!

I can tell ... you are hoping that BTI can pull it off and .... you can say ...see I told you!

........... not going to happen!

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia